Histiocitosis maligna

  1. Oscar Ruiz
  2. Willy Quiñones
  3. Oscar Misad
  4. Carlos Delgado
  5. Sergio Ronceros
  6. Manuela Marangoni
  7. Luz Bardales
  8. Rafael Reyes
  9. Alfredo Castillo
  10. Katia Urrutia
Journal:
Anales de la Facultad de Medicina

ISSN: 1025-5583,  1609-9419

Year of publication: 2004

Volume: 65

Issue: 4

Pages: 255-259

Type: Article

DIALNET GOOGLE SCHOLAR lock_openDialnet editor

More publications in: Anales de la Facultad de Medicina

Abstract

Fourteen year-old male patient referred from Huancayo who presented one month gastricintolerance, jaundice, fever and a lymph proliferative syndrome. Laboratory tests revealedsevere pancytopenia due to phagocytosis. Haematologic and anatomy-pathology diagnosis washuman malignant histiocytosis. We present this case due to its low frequency and the emergencycharacter of the disease.

Bibliographic References

  • Dearth J, Hunter D, Kelly D, Crist W. Sinus histiocytosiswith massive lymphadenopathy. CA Cancer J Clin.1980;30(1):55-8.
  • Favara BE, Feller AC, Pauli M, Jaffe ES, Weiss LM, AricoM. Contemporary classification of histiocytic disorders. The WHO Committee on Histiocytic/ReticulumCell Proliferations. Reclassification Working Group of theHistiocyte Society. Med Pediatr Oncol. 1997;29:157-66.
  • Fernandez C, Martinez MA, Ricard P, Ballestin C, AssoA, Hernandez E, et al. Histiocitosis maligna: estudio de 8casos. Med Clin (Barc). 1988;90:437-42.
  • Gogusev J, Barbey S, Nezelof C. Human malignanthistiocytosis CD30+ DEL cell line differentiates intomacrophage-like cells when treated with a phorbol diester.Cancer Research. 1991;51(20):5712-5.
  • Healey PJ, Hight DW. Abdominal masses. En: Wyllie R,Hyams JS, eds. Pediatric gastrointestinal disease. 2a ed.Philadelphia: WB Saunders Company; 1999. p. 281-92.
  • Jaffe ES, Harris NL, Stein H, Vardiman J, eds. Pathologyand Genetics of Tumours of Haematopoietic and LymphoidTissues: WHO Classification of Tumours. Lyons: IARCPress; 2001. p. 230-5, 273-89.
  • Johnston RB Jr. Monocytes and macrophages. N Engl JMed. 1998;318:747-52.
  • Kogan SC, Ward JM, Anver MR, Berman JJ, Brayton C,Cardiff RD, et al. Bethesda proposals for classification ofnonlymphoid hematopoietic neoplasms in mice. Blood.2002;100(1):238-45.
  • Komp DM, Perry MC. The histiocytic syndromes. SeminOncol. 1991;18:1-62.
  • Lipton JM. Histiocytic disorders. En: Hoffman R, BenzEJ, Shattil SJ, Furie B, Cohe HJ, Silberstein LE Hematology. Basic principles and practice. 3a ed.Nueva York: Churchill Livingstone; 2000. p. 783-96.
  • Loredo A. El niño con hepatoesplenomegalia de origen incierto.En: Loredo A, ed. Medicina Interna Pediátrica. 3a ed. MéxicoDF: Mc Graw Hill Interamericana; 1997. p. 445-55.
  • Reiner AP, Spivak JL. Hematophagic histiocytosis. A reportof 23 new patients and a review of the literature. Medicine(Baltimore). 1988;67:369-88.
  • Richard E, Behrman N. Tratado de Pediatria. 14a ed. Madrid:Mc Graw Hill Interamericana; 1992. p. 1225-30, 2141-43.
  • Sans J. Hematología Clínica. 4ª ed. Madrid: ElsevierScience; 2001. p. 547-64.
  • Sastre Urgelles A. Hemophagocytic syndromes: Think ofthem... because they are a reality. An Esp Pediatr.2002;56:95-8.
  • Torres A, Fernández R, Taylor V, Corona P, LongchongM. Biopsia de médula ósea: Patrones morfológicos de lashemopatías y tumores sólidos en pediatría. Rev CubanaPediatr. 1996;68(3):171-6.
Data source: Dialnet